ASCO GI 2023 Highlights: Updates on HCC & CCA

In this episode, Drs. Maria Reig and Richard Finn will dive deep into the updates and groundbreaking research presented at the ASCO GI Meeting in January 2023. They will explore the latest advancements in the field of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Here is what you can expect from this podcast:

• Updates on the efficacy and safety of new drugs in HCC

• The evolving landscape of systemic therapy for cholangiocarcinoma

• Evolving questions in sequencing systemic therapy in HCC

• The role of systemic therapy in the early stages of HCC

Incyte has co-funded this podcast and all content has been developed independently by ILCA.